Application of MCM8 as gastric adenocarcinoma metastasis marker

• Main Authors: SONG HONGTAO, MA CUI
• Format: Patent
• Language: Chinese; English
• Published: 24.11.2017
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; ENZYMOLOGY; HUMAN NECESSITIES; HYGIENE; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; PHYSICS; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; TESTING; VINEGAR; WINE

The invention discloses MCM8 serving as a diagnosis and treatment target of gastric adenocarcinoma. Therefore, the MCM8 can be used for developing products for diagnosing the gastric adenocarcinoma and developing medicines for treating the gastric adenocarcinoma. The research achievement of the invention provides theoretical basis for a clinicist to formulate personalized treatment programs and can provide a new medicine target point for developing gastric adenocarcinoma medicines. 本发明公开了MCM8作为胃腺癌的诊治靶标。据此可将MCM8用于开发诊断胃腺癌的产品、开发治疗胃腺癌的药物。本发明的研究成果为临床医师制定个性化治疗方案提供理论基础、并且能够为胃腺癌药物的开发提供新的药物靶点。